Related Experiment Video
Updated: Jun 7, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
MicroRNAs and atrial fibrillation: new fundamentals
Zhiguo Wang1, Yanjie Lu, Baofeng Yang
1Research Center, Montreal Heart Institute, 5000 Belanger East, Montreal, Canada PQ H1T 1C8. wz.email@gmail.com
Abstract:
Atrial fibrillation (AF) is the most commonly encountered clinical arrhythmia associated with pronounced morbidity, mortality, and socio-economic burden. This pathological entity is associated with an altered expression profile of genes that are important for atrial function. MicroRNAs (miRNAs), a new class of non-coding mRNAs of around 22 nucleotides in length, have rapidly emerged as one of the key players in the gene expression regulatory network. The potential roles of miRNAs in controlling AF have recently been investigated. The studies have provided some promising results for our better understanding of the molecular mechanisms of AF. In this review article, we provide a synopsis of the studies linking miRNAs to cardiac excitability and other processes pertinent to AF. To introduce the main topic, we discuss basic knowledge about miRNA biology and our current understanding of mechanisms for AF. The most up-to-date research data on the possible roles of miRNAs in AF initiation and maintenance are presented, and the available experimental results on miRNA and AF are discussed. Some speculations pertinent to the subject are made. Finally, perspectives on future directions of research on miRNAs in AF are provided.
Insights
MicroRNAs (miRNAs) are key regulators of gene expression implicated in atrial fibrillation (AF). This review explores current research on miRNA roles in AF development and maintenance, offering future research directions.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia with significant health and economic impacts.
- AF pathogenesis involves altered gene expression crucial for atrial function.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are increasingly recognized in cardiovascular disease.
Purpose of the Study:
- To review the current understanding of microRNA (miRNA) involvement in atrial fibrillation (AF).
- To discuss the molecular mechanisms linking miRNAs to cardiac excitability and AF.
- To present recent research findings and future perspectives on miRNAs in AF.
Main Methods:
- Literature review of studies investigating miRNA roles in AF.
- Analysis of experimental data on miRNA expression and function in AF models.
- Synthesis of current knowledge on miRNA biology and AF mechanisms.
Main Results:
- Emerging evidence highlights miRNAs as critical regulators in AF.
- Specific miRNAs are implicated in the initiation and maintenance of AF.
- miRNA research offers insights into the molecular underpinnings of AF.
Conclusions:
- MicroRNAs represent a significant area of research for understanding and potentially treating AF.
- Further investigation into miRNA-mediated gene regulation is crucial for advancing AF therapies.
- Future research should focus on the therapeutic potential of targeting miRNAs in AF.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Mitral Regurgitation I: Introduction
Dysrhythmias I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

